Protea - Articles and news items

Proteomic mass spectrometry imaging for detecting malignant melanoma

Blog, Z Homepage promo / 26 April 2016 / Victoria White, Digital Content Producer

In an exclusive interview, Erin Seeley of Protea Biosciences discusses Proteomic Mass Spectrometry Imaging and Protea’s recently announced license agreement with Yale…

Alessandro Baldi, VP and General Manager, Protea

Protea interviewed by European Pharmaceutical Review at analytica 2012

Videos / 3 May 2012 / Freddy White, European Pharmaceutical Review

Alessandro Baldi, VP and General Manager at Protea speaks to Freddy White, Director of the European Pharmaceutical Review at analytica 2012.

In-Depth Focus: Mass Spectrometry

In-depth focus – Mass Spectrometry

Chromatography, Issue 2 2012, Supplements / 25 April 2012 / Ana Rita Angelino, Min Yang, Tasso Miliotis, Constanze Hilgendorf, Anthony Bristow, George McLeod, Detlev Hochmuth, Alessandro Baldi, Gary Harland

Mass spectrometry in drug discovery – Proteomics, small molecules and metablomics.
Quantification of membrane drug transporters and application in drug discovery and development.
Mass spectrometry leaders roundtable.


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...